← Open Payments lookup

BRANDY BYRD: Open Payments

NPI 1013491992 · BRANDON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,270 in 100 payments from 13 companies in 2025. Trend: 2023 $1,398 · 2024 $1,721 · 2025 $2,270

Food & beverage: $2,059Education: $211
CompanyPaymentsAmount
Axsome Therapeutics, Inc.13$483
Teva Pharmaceuticals USA, Inc.9$360
Alkermes, Inc.12$190
Neurocrine BioSciences, Inc.9$175
ABBVIE INC.12$172
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$171
E.R. Squibb & Sons, L.L.C.10$163
Lundbeck LLC8$160
Janssen Pharmaceuticals, Inc7$154
Otsuka America Pharmaceutical, Inc.7$137

Products named: Auvelity, ARISTADA, INGREZZA, VRAYLAR, CAPLYTA, REXULTI, COBENFY, INVEGA SUSTENNA.

Industry payments across MS — which companies pay providers there.